Diabetes mellitus (DM) is a metabolic disease, which arises from a complete deficiency of insulin production or inability to utilize this hormone. Potential antibodies, genes associated with diabetes have the potential to be therapeutic targets for diabetes. As an experienced drug discovery company, Ace Therapeutics can provide the therapy and drug discovery services related to diabetes.
Diabetes mellitus is a serious and lifelong condition commonly characterized by abnormally elevated blood glucose levels due to a failure in insulin production or a decrease in insulin sensitivity and function. If left untreated, diabetes can cause many health complications. Acute complications can include diabetic ketoacidosis, hyperosmolar hyperglycemic state, or death. Besides insulin and oral hypoglycemic agents, other treatments such as gene therapy and induced β-cells regeneration can be introduced to manage diabetes.
mAb therapies to ameliorate type 1 diabetes (Ke, Qi et al. 2021)
The compound has the desired activity in a compound screen and whose activity is confirmed upon retesting. Ace Therapeutics can provide a complementary set of technologies to help with the drugs discovery. Our services include but not limited to the followings.
Developing antidiabetics (inhibitors and activators, etc.) for related targets and designing and developing drug delivery system.
Developing diabetes-related monoclonal antibody, antibody drug conjugate (ADC), bispecific antibody, allosteric antibody, etc.
Highly Customizable
One-stop Services
High Quality
Professional Team
Ace Therapeutics can accelerate the therapeutic development and drug discovery process about diabetes for our clients worldwide. Our assays are developed and processed with the highest standard and the results are delivered on time without compromising quality. Most of those assays are suitable for drug discovery. Please feel free to contact us.
